Table of Contents
Journal of Signal Transduction
Volume 2011 (2011), Article ID 109746, 8 pages
http://dx.doi.org/10.1155/2011/109746
Review Article

Role of RNA-Binding Proteins in MAPK Signal Transduction Pathway

1Laboratory of Molecular Pharmacogenomics, School of Pharmaceutical Sciences, Kinki University, 3-4-1 Kowakae, Higashi-Osaka 577-8502, Japan
2Research Fellow of the Japan Society for the Promotion of Science, 1-8 Chiyoda-ku, Tokyo 102-8472, Japan

Received 31 August 2010; Revised 20 January 2011; Accepted 9 February 2011

Academic Editor: Fred Schaper

Copyright © 2011 Reiko Sugiura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Sunnerhagen, “Cytoplasmatic post-transcriptional regulation and intracellular signalling,” Molecular Genetics and Genomics, vol. 277, no. 4, pp. 341–355, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. W. Eberhardt, A. Doller, E. L. S. Akool, and J. Pfeilschifter, “Modulation of mRNA stability as a novel therapeutic approach,” Pharmacology and Therapeutics, vol. 114, no. 1, pp. 56–73, 2007. View at Publisher · View at Google Scholar · View at PubMed
  3. J. Mata, S. Marguerat, and J. Bähler, “Post-transcriptional control of gene expression: a genome-wide perspective,” Trends in Biochemical Sciences, vol. 30, no. 9, pp. 506–514, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. R. Sugiura, T. Toda, H. Shuntoh, M. Yanagida, and T. Kuno, “pmp1+, a suppressor of calcineurin deficiency, encodes a novel MAP kinase phosphatase in fission yeast,” EMBO Journal, vol. 17, no. 1, pp. 140–148, 1998. View at Publisher · View at Google Scholar · View at PubMed
  5. T. Toda, S. Dhut, G. Superti-Furga et al., “The fission yeast pmk1 gene encodes a novel mitogen-activated protein kinase homolog which regulates cell integrity and functions coordinately with the protein kinase C pathway,” Molecular and Cellular Biology, vol. 16, no. 12, pp. 6752–6764, 1996. View at Google Scholar
  6. R. Sugiura, T. Toda, S. Dhut, H. Shuntoh, and T. Kuno, “The MAPK kinase Pek1 acts as a phosphorylation-dependent molecular switch,” Nature, vol. 399, no. 6735, pp. 479–483, 1999. View at Publisher · View at Google Scholar · View at PubMed
  7. R. Sugiura, A. Kita, Y. Shimizu, H. Shuntoh, S. O. Slo, and T. Kuno, “Feedback regulation of MAPK signalling by an RNA-binding protein,” Nature, vol. 424, no. 6951, pp. 961–965, 2003. View at Publisher · View at Google Scholar · View at PubMed
  8. R. J. Buckanovich and R. B. Darnell, “The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo,” Molecular and Cellular Biology, vol. 17, no. 6, pp. 3194–3201, 1997. View at Google Scholar
  9. S. M. Keyse and E. A. Emslie, “Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine phosphatase,” Nature, vol. 359, no. 6396, pp. 644–647, 1992. View at Publisher · View at Google Scholar · View at PubMed
  10. T. Noguchi, R. Metz, L. Chen, M. G. Mattei, D. Carrasco, and R. Bravo, “Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth,” Molecular and Cellular Biology, vol. 13, no. 9, pp. 5195–5205, 1993. View at Google Scholar
  11. H. Sun, C. H. Charles, L. F. Lau, and N. K. Tonks, “MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo,” Cell, vol. 75, no. 3, pp. 487–493, 1993. View at Publisher · View at Google Scholar
  12. C. C. Franklin and A. S. Kraft, “Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells,” Journal of Biological Chemistry, vol. 272, no. 27, pp. 16917–16923, 1997. View at Publisher · View at Google Scholar
  13. J. Li, M. Gorospe, D. Hutter, J. Barnes, S. M. Keyse, and Y. Liu, “Transcriptional induction of MKP-1 in response to stress is associated with histone H3 phosphorylation-acetylation,” Molecular and Cellular Biology, vol. 21, no. 23, pp. 8213–8224, 2001. View at Publisher · View at Google Scholar · View at PubMed
  14. M. Camps, A. Nichols, and S. Arkinstall, “Dual specificity phosphatases: a gene family for control of MAP kinase function,” FASEB Journal, vol. 14, no. 1, pp. 6–16, 2000. View at Google Scholar
  15. S. M. Keyse, “Protein phosphatases and the regulation of mitogen-activated protein kinase signalling,” Current Opinion in Cell Biology, vol. 12, no. 2, pp. 186–192, 2000. View at Publisher · View at Google Scholar
  16. S. M. Keyse, “Dual-specificity MAP kinase phosphatases (MKPs) and cancer,” Cancer and Metastasis Reviews, vol. 27, no. 2, pp. 253–261, 2008. View at Publisher · View at Google Scholar · View at PubMed
  17. Y. J. Arnoldussen and F. Saatcioglu, “Dual specificity phosphatases in prostate cancer,” Molecular and Cellular Endocrinology, vol. 309, no. 1-2, pp. 1–7, 2009. View at Publisher · View at Google Scholar · View at PubMed
  18. K. K. Haagenson and G. S. Wu, “Mitogen activated protein kinase phosphatases and cancer,” Cancer Biology and Therapy, vol. 9, no. 5, pp. 337–340, 2010. View at Google Scholar
  19. C. Casals-Casas, E. Álvarez, M. Serra et al., “CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation,” European Journal of Immunology, vol. 39, no. 7, pp. 1902–1913, 2009. View at Publisher · View at Google Scholar · View at PubMed
  20. H. R. Wong, K. E. Dunsmore, K. Page, and T. P. Shanley, “Heat shock-mediated regulation of MKP-1,” American Journal of Physiology, vol. 289, no. 5, pp. C1152–C1158, 2005. View at Publisher · View at Google Scholar · View at PubMed
  21. Y. Kuwano, H. H. Kim, K. Abdelmohsen et al., “MKP-1 mRNA stabilization and translational control by RNA-binding proteins HuR and NF90,” Molecular and Cellular Biology, vol. 28, no. 14, pp. 4562–4575, 2008. View at Publisher · View at Google Scholar · View at PubMed
  22. Y. Kuwano and M. Gorospe, “Protecting the stress response, guarding the MKP-1 mRNA,” Cell Cycle, vol. 7, no. 17, pp. 2640–2642, 2008. View at Google Scholar
  23. N. Y. Lin, C. T. Lin, and C. J. Chang, “Modulation of immediate early gene expression by tristetraprolin in the differentiation of 3T3-L1 cells,” Biochemical and Biophysical Research Communications, vol. 365, no. 1, pp. 69–74, 2008. View at Publisher · View at Google Scholar · View at PubMed
  24. J. Emmons, W. H. D. Townley-Tilson, K. M. Deleault et al., “Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation,” RNA, vol. 14, no. 5, pp. 888–902, 2008. View at Publisher · View at Google Scholar · View at PubMed
  25. M. Bros, N. Wiechmann, V. Besche et al., “The RNA binding protein tristetraprolin influences the activation state of murine dendritic cells,” Molecular Immunology, vol. 47, no. 5, pp. 1161–1170, 2010. View at Publisher · View at Google Scholar · View at PubMed
  26. O. Bermudez, P. Jouandin, J. Rottier, C. Bourcier, G. Pagès, and C. Gimond, “Post-transcriptional regulation of the DUSP6/MKP-3 phosphatase by MEK/ERK signaling and hypoxia,” Journal of Cellular Physiology, vol. 226, no. 1, pp. 276–284, 2011. View at Publisher · View at Google Scholar · View at PubMed
  27. J. L. E. Dean, M. Brook, A. R. Clark, and J. Saklatvala, “p38 Mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes,” Journal of Biological Chemistry, vol. 274, no. 1, pp. 264–269, 1999. View at Publisher · View at Google Scholar
  28. N. H. Lee and R. L. Malek, “Nerve growth factor regulation of m4 muscarinic receptor mRNA stability but not gene transcription requires mitogen-activated protein kinase activity,” Journal of Biological Chemistry, vol. 273, no. 35, pp. 22317–22325, 1998. View at Publisher · View at Google Scholar
  29. S. Huang, L. New, Z. Pan, J. Han, and G. R. Nemerow, “Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity,” Journal of Biological Chemistry, vol. 275, no. 16, pp. 12266–12272, 2000. View at Publisher · View at Google Scholar
  30. M. Lasa, K. R. Mahtani, A. Finch, G. Brewer, J. Saklatvala, and A. R. Clark, “Regulation of cyclooxygenase 2 mRNA stability by the mitogen- activated protein kinase p38 signaling cascade,” Molecular and Cellular Biology, vol. 20, no. 12, pp. 4265–4274, 2000. View at Publisher · View at Google Scholar
  31. K. Rutault, C. A. Hazzalin, and L. C. Mahadevan, “Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-α (TNF-α) mRNA induction: evidence for selective destabilization of TNF-α transcripts,” Journal of Biological Chemistry, vol. 276, no. 9, pp. 6666–6674, 2001. View at Publisher · View at Google Scholar · View at PubMed
  32. E. Carballo, H. Cao, WI. S. Lai, E. A. Kennington, D. Campbell, and P. J. Blackshear, “Decreased sensitivity of tristetraprolin-deficient cells to p38 inhibitors suggests the involvement of tristetraprolin in the p38 signaling pathway,” Journal of Biological Chemistry, vol. 276, no. 45, pp. 42580–42587, 2001. View at Publisher · View at Google Scholar · View at PubMed
  33. K. R. Mahtani, M. Brook, J. L. E. Dean, G. Sully, J. Saklatvala, and A. R. Clark, “Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability,” Molecular and Cellular Biology, vol. 21, no. 19, pp. 6461–6469, 2001. View at Publisher · View at Google Scholar
  34. L. Sun, G. Stoecklin, S. Van Way et al., “Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-α mRNA,” Journal of Biological Chemistry, vol. 282, no. 6, pp. 3766–3777, 2007. View at Publisher · View at Google Scholar · View at PubMed
  35. C. Yang, D. A. Maiguel, and F. Carrier, “Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins,” Nucleic Acids Research, vol. 30, no. 10, pp. 2251–2260, 2002. View at Google Scholar
  36. H. Habelhah, K. Shah, L. Huang et al., “ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation,” Nature Cell Biology, vol. 3, no. 3, pp. 325–330, 2001. View at Publisher · View at Google Scholar · View at PubMed
  37. J. W. Chang, T. Koike, and M. Iwashima, “hnRNP-K is a nuclear target of TCR-activated ERK and required for T-cell late activation,” International Immunology, vol. 21, no. 12, pp. 1351–1361, 2009. View at Publisher · View at Google Scholar · View at PubMed
  38. H. C. Reinhardt, P. Hasskamp, I. Schmedding et al., “DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization,” Molecular Cell, vol. 40, no. 1, pp. 34–49, 2010. View at Publisher · View at Google Scholar · View at PubMed
  39. J. L. E. Dean, R. Wait, K. R. Mahtani, G. Sully, A. R. Clark, and J. Saklatvala, “The 3 Untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR,” Molecular and Cellular Biology, vol. 21, no. 3, pp. 721–730, 2001. View at Publisher · View at Google Scholar · View at PubMed
  40. F. Bollig, R. Winzen, M. Gaestel, S. Kostka, K. Resch, and H. Holtmann, “Affinity purification of ARE-binding proteins identifies poly(A)-binding protein 1 as a potential substrate in MK2-induced mRNA stabilization,” Biochemical and Biophysical Research Communications, vol. 301, no. 3, pp. 665–670, 2003. View at Publisher · View at Google Scholar
  41. R. Satoh, T. Morita, H. Takada et al., “Role of the RNA-binding protein Nrd1 and Pmk1 mitogen-activated protein kinase in the regulation of myosin mRNA stability in fission yeast,” Molecular Biology of the Cell, vol. 20, no. 9, pp. 2473–2485, 2009. View at Publisher · View at Google Scholar · View at PubMed
  42. M. A. Rodríguez-Gabriel, G. Burns, W. H. McDonald et al., “RNA-binding protein Csx1 mediates global control of gene expression in response to oxidative stress,” EMBO Journal, vol. 22, no. 23, pp. 6256–6266, 2003. View at Publisher · View at Google Scholar · View at PubMed
  43. M. A. E. Frevel, T. Bakheet, A. M. Silva, J. G. Hissong, K. S. A. Khabar, and B. R. G. Williams, “p38 mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts,” Molecular and Cellular Biology, vol. 23, no. 2, pp. 425–436, 2003. View at Publisher · View at Google Scholar
  44. G. A. Taylor, E. Carballo, D. M. Lee et al., “A pathogenetic role for TNFα in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency,” Immunity, vol. 4, no. 5, pp. 445–454, 1996. View at Publisher · View at Google Scholar
  45. E. Hitti, T. Iakovleva, M. Brook et al., “Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element,” Molecular and Cellular Biology, vol. 26, no. 6, pp. 2399–2407, 2006. View at Publisher · View at Google Scholar · View at PubMed
  46. C. A. Chrestensen, M. J. Schroeder, J. Shabanowitz et al., “MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including ser, a site required for 14-3-3 binding,” Journal of Biological Chemistry, vol. 279, no. 11, pp. 10176–10184, 2004. View at Publisher · View at Google Scholar · View at PubMed
  47. B. A. Johnson, J. R. Stehn, M. B. Yaffe, and T. K. Blackwell, “Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms,” Journal of Biological Chemistry, vol. 277, no. 20, pp. 18029–18036, 2002. View at Publisher · View at Google Scholar · View at PubMed
  48. G. Stoecklin, T. Stubbs, N. Kedersha et al., “MK2-induced tristetraprolin:14-3-3 Complexes prevent stress granule association and ARE-mRNA decay,” EMBO Journal, vol. 23, no. 6, pp. 1313–1324, 2004. View at Publisher · View at Google Scholar · View at PubMed
  49. F. P. Marchese, A. Aubareda, C. Tudor, J. Saklatvala, A. R. Clark, and J. L. E. Dean, “MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment,” Journal of Biological Chemistry, vol. 285, no. 36, pp. 27590–27600, 2010. View at Publisher · View at Google Scholar · View at PubMed
  50. S. L. Clement, C. Scheckel, G. Stoecklin, and J. Lykke-Andersen, “Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment,” Molecular and Cellular Biology, vol. 31, no. 2, pp. 256–266, 2011. View at Publisher · View at Google Scholar · View at PubMed
  51. S. Rousseau, N. Morrice, M. Peggie, D. G. Campbell, M. Gaestel, and P. Cohen, “Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs,” EMBO Journal, vol. 21, no. 23, pp. 6505–6514, 2002. View at Publisher · View at Google Scholar
  52. P. Briata, S. V. Forcales, M. Ponassi et al., “p38-Dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts,” Molecular Cell, vol. 20, no. 6, pp. 891–903, 2005. View at Publisher · View at Google Scholar · View at PubMed
  53. S. Vasudevan and S. W. Peltz, “Regulated ARE-mediated mRNA decay in Saccharomyces cerevisiae,” Molecular Cell, vol. 7, no. 6, pp. 1191–1200, 2001. View at Publisher · View at Google Scholar
  54. L. Xiao, J. N. Rao, T. Zou et al., “Polyamines regulate the stability of activating transcription factor-2 mRNA through RNA-binding protein HuR in intestinal epithelial cells,” Molecular Biology of the Cell, vol. 18, no. 11, pp. 4579–4590, 2007. View at Publisher · View at Google Scholar · View at PubMed
  55. D. McCollum, M. K. Balasubramanian, L. E. Pelcher, S. M. Hemmingsen, and K. L. Gould, “Schizosaccharomyces pombe cdc4+ gene encodes a novel EF-hand protein essential for cytokinesis,” Journal of Cell Biology, vol. 130, no. 3, pp. 651–660, 1995. View at Publisher · View at Google Scholar
  56. C. M. Slupsky, M. Desautels, T. Huebert, R. Zhao, S. M. Hemmingsen, and L. P. McIntosh, “Structure of Cdc4p, a contractile ring protein essential for cytokinesis in Schizosaccharomyces pombe,” Journal of Biological Chemistry, vol. 276, no. 8, pp. 5943–5951, 2001. View at Publisher · View at Google Scholar · View at PubMed
  57. L. M. Dember, N. D. Kim, K. Q. Liu, and P. Anderson, “Individual RNA recognition motifs of TIA-1 and TIAR have different RNA binding specificities,” Journal of Biological Chemistry, vol. 271, no. 5, pp. 2783–2788, 1996. View at Publisher · View at Google Scholar
  58. N. L. Kedersha, M. Gupta, W. Li, I. Miller, and P. Anderson, “RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2α to the assembly of mammalian stress granules,” Journal of Cell Biology, vol. 147, no. 7, pp. 1431–1441, 1999. View at Publisher · View at Google Scholar
  59. P. Förch, O. Puig, N. Kedersha et al., “The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing,” Molecular Cell, vol. 6, no. 5, pp. 1089–1098, 2000. View at Google Scholar
  60. F. D. Gatto-Konczak, C. F. Bourgeois, C. Le Guiner et al., “The RNA-binding protein TIA-1 is a novel mammalian splicing regulator acting through intron sequences adjacent to a 5' splice site,” Molecular and Cellular Biology, vol. 20, no. 17, pp. 6287–6299, 2000. View at Publisher · View at Google Scholar
  61. A. Hammet, B. L. Pike, and J. Heierhorst, “Posttranscriptional regulation of the RAD5 DNA repair gene by the dun1 kinase and the Pan2-Pan3 poly(A)-nuclease complex contributes to survival of replication blocks,” Journal of Biological Chemistry, vol. 277, no. 25, pp. 22469–22474, 2002. View at Publisher · View at Google Scholar · View at PubMed
  62. K. S. A. Khabar, “Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements,” Cellular and Molecular Life Sciences, vol. 67, no. 17, pp. 2937–2955, 2010. View at Publisher · View at Google Scholar · View at PubMed
  63. D. Kontoyiannis, M. Pasparakis, T. T. Pizarro, F. Cominelli, and G. Kollias, “Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU- rich elements: Implications for joint and gut-associated immunopathologies,” Immunity, vol. 10, no. 3, pp. 387–398, 1999. View at Google Scholar
  64. G. Kollias, D. Kontoyiannis, E. Douni, and G. Kassiotis, “The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized ‘anti-TNF’ therapies,” Current Directions in Autoimmunity, vol. 5, pp. 30–50, 2002. View at Google Scholar
  65. S. Kumar, J. Boehm, and J. C. Lee, “P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases,” Nature Reviews Drug Discovery, vol. 2, no. 9, pp. 717–726, 2003. View at Google Scholar
  66. P. Anderson, “Post-transcriptional control of cytokine production,” Nature Immunology, vol. 9, no. 4, pp. 353–359, 2008. View at Publisher · View at Google Scholar · View at PubMed
  67. M. Gaestel, A. Kotlyarov, and M. Kracht, “Targeting innate immunity protein kinase signalling in inflammation,” Nature Reviews Drug Discovery, vol. 8, no. 6, pp. 480–499, 2009. View at Publisher · View at Google Scholar · View at PubMed
  68. A. Belle, A. Tanay, L. Bitincka, R. Shamir, and E. K. O'Shea, “Quantification of protein half-lives in the budding yeast proteome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13004–13009, 2006. View at Publisher · View at Google Scholar · View at PubMed
  69. N. Ronkina, M. B. Menon, J. Schwermann et al., “Stress induced gene expression: a direct role for MAPKAP kinases in transcriptional activation of immediate early genes,” Nucleic Acids Research . In press.
  70. K. M. Deleault, S. J. Skinner, and S. A. Brooks, “Tristetraprolin regulates TNF TNF-α mRNA stability via a proteasome dependent mechanism involving the combined action of the ERK and p38 pathways,” Molecular Immunology, vol. 45, no. 1, pp. 13–24, 2008. View at Publisher · View at Google Scholar · View at PubMed